Skip to main content
. 2023 Jul 4;3(5):724–735. doi: 10.1016/j.jacasi.2023.05.010

Figure 2.

Figure 2

APAC Study Leadership/Collaboration and Asian Race Enrollment

Proportion of lead authors (A) and trial collaborators (ie, remaining non-lead authors) (B) from APAC region by year between 2011 and 2020. Proportion of enrolled participants of Asian race (C) and from APAC region (D) by year between 2011 and 2020. Dotted line represents the estimated APAC prevalence of CVD ∼60% as an aspirational benchmark for representativeness. APAC = Asia-Pacific; CVD = cardiovascular disease; RCT = randomized controlled trial.